Dose-dependent absorption and elimination of cefadroxil in man

The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased si...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical pharmacology Vol. 41; no. 2; p. 179
Main Authors Garrigues, T M, Martin, U, Peris-Ribera, J E, Prescott, L F
Format Journal Article
LanguageEnglish
Published Germany 01.01.1991
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased significantly from 15.1 to 10.7 and 7.6 mg.l-1, while the corresponding normalized areas under the plasma concentration-time curves from 0 to 2 h decreased significantly from 1258 to 946 and 801 min.mg.l-1. When the same subjects were given 5 mg.kg-1 of cefadroxil together with 45 mg.kg-1 of cephalexin, the absorption of cefadroxil was slowed to a similar or greater extent than with the high dose of cefadroxil. Although the absorption rate decreased as the dose increased, the systemic availability of cefadroxil was essentially complete at all doses, as judged by the 24 h urinary recoveries of the antibiotic. Kinetic analysis of the plasma concentration-time curves gave the best fit with a zero-order followed by a first-order absorption process, consistent with saturable intestinal absorption of cefadroxil. The elimination rate of cefadroxil was directly related to dose and plasma concentrations, and the clearance at the dose of 5 mg.kg-1 was significantly increased by the simultaneous administration of high-dose cephalexin. The renal clearance of cefadroxil ranged from 98 ml.min.l-1 at total plasma cephalosporin (cefadroxil + cephalexin) concentrations less than 2.5 mg.l-1 to 156 mg.l-1 at concentrations greater than 40 mg.l-1.
AbstractList The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30 mg.kg-1. As the dose of cefadroxil increased from 5 to 15 and 30 mg.kg-1, the peak plasma concentrations, normalized to 5 mg.kg-1, decreased significantly from 15.1 to 10.7 and 7.6 mg.l-1, while the corresponding normalized areas under the plasma concentration-time curves from 0 to 2 h decreased significantly from 1258 to 946 and 801 min.mg.l-1. When the same subjects were given 5 mg.kg-1 of cefadroxil together with 45 mg.kg-1 of cephalexin, the absorption of cefadroxil was slowed to a similar or greater extent than with the high dose of cefadroxil. Although the absorption rate decreased as the dose increased, the systemic availability of cefadroxil was essentially complete at all doses, as judged by the 24 h urinary recoveries of the antibiotic. Kinetic analysis of the plasma concentration-time curves gave the best fit with a zero-order followed by a first-order absorption process, consistent with saturable intestinal absorption of cefadroxil. The elimination rate of cefadroxil was directly related to dose and plasma concentrations, and the clearance at the dose of 5 mg.kg-1 was significantly increased by the simultaneous administration of high-dose cephalexin. The renal clearance of cefadroxil ranged from 98 ml.min.l-1 at total plasma cephalosporin (cefadroxil + cephalexin) concentrations less than 2.5 mg.l-1 to 156 mg.l-1 at concentrations greater than 40 mg.l-1.
Author Garrigues, T M
Prescott, L F
Peris-Ribera, J E
Martin, U
Author_xml – sequence: 1
  givenname: T M
  surname: Garrigues
  fullname: Garrigues, T M
  organization: Department of Pharmacology and Pharmaceutics, University of Valencia, Spain
– sequence: 2
  givenname: U
  surname: Martin
  fullname: Martin, U
– sequence: 3
  givenname: J E
  surname: Peris-Ribera
  fullname: Peris-Ribera, J E
– sequence: 4
  givenname: L F
  surname: Prescott
  fullname: Prescott, L F
BackLink https://www.ncbi.nlm.nih.gov/pubmed/1743250$$D View this record in MEDLINE/PubMed
BookMark eNotj8tOwzAURL0oKm1hwx7JPxC4fsX2BgkKBaRKbGBd3cTXklFiR0mQ4O95dTWasxidWbNFLpkYuxBwJQDs9d0OQNbGC71gKwAlqtpbOGXraXoHEMaDWrKlsFpJAyt2c18mqgINlAPlmWMzlXGYU8kcc-DUpT5l_Osl8pYihrF8po6nzHvMZ-wkYjfR-TE37G338Lp9qvYvj8_b233VKmXmyiqpgZw0SBiDNWSc1Y1GSejaH9Q6g76uTXS6Vr_y0kUDwaPx1EQT5YZd_u8OH01P4TCMqcfx63D8Ib8BwNRIyQ
CitedBy_id crossref_primary_10_1021_mp100130b
crossref_primary_10_3389_fphar_2021_692741
crossref_primary_10_1007_s11095_013_1168_3
crossref_primary_10_1124_dmd_105_006791
crossref_primary_10_1007_s11095_012_0937_8
crossref_primary_10_1208_s12249_024_02811_z
crossref_primary_10_1007_s11095_023_03597_8
crossref_primary_10_1016_0378_5173_94_00397_N
crossref_primary_10_1016_0378_5173_95_04342_X
crossref_primary_10_1177_0091270002250613
crossref_primary_10_1016_j_etap_2014_10_007
crossref_primary_10_1016_j_bcp_2016_03_008
crossref_primary_10_1124_dmd_107_015263
crossref_primary_10_1517_17425255_2_4_505
crossref_primary_10_1124_jpet_104_073098
crossref_primary_10_1021_mp500497p
crossref_primary_10_1111_j_1365_2710_2010_01206_x
crossref_primary_10_3109_00498254_2015_1080881
crossref_primary_10_1007_s00424_004_1326_x
crossref_primary_10_1034_j_1600_0773_2002_900601_x
crossref_primary_10_1007_s10928_022_09832_w
crossref_primary_10_1124_dmd_118_084236
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1007/BF00265914
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 1743250
Genre Clinical Trial
Randomized Controlled Trial
Journal Article
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
04C
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3SX
3V.
4.4
406
408
409
40D
40E
53G
5QI
5RE
5VS
67N
67Z
6NX
6PF
78A
7RV
7X7
88E
8AO
8FI
8FJ
8FW
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADOJX
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADYPR
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFGCZ
AFKRA
AFLOW
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BMSDO
BPHCQ
BSONS
BVXVI
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
ECM
ECT
EIF
EIHBH
EIOEI
EJD
EMB
EMOBN
EN4
EPAXT
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M4Y
MA-
MK0
N2Q
N9A
NAPCQ
NB0
NDZJH
NPM
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SBY
SCLPG
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZN
T13
T16
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK6
WK8
WOW
Y6R
YLTOR
Z45
Z7U
Z7V
Z7W
Z81
Z82
Z83
Z87
Z8O
Z8P
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
ID FETCH-LOGICAL-c335t-73240e825aeafd75e5874b4a2ea8ceafc85a9665f8463659128f50d9a59ebf5f2
ISSN 0031-6970
IngestDate Wed Feb 19 00:33:43 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c335t-73240e825aeafd75e5874b4a2ea8ceafc85a9665f8463659128f50d9a59ebf5f2
PMID 1743250
ParticipantIDs pubmed_primary_1743250
PublicationCentury 1900
PublicationDate 1991-01-01
PublicationDateYYYYMMDD 1991-01-01
PublicationDate_xml – month: 01
  year: 1991
  text: 1991-01-01
  day: 01
PublicationDecade 1990
PublicationPlace Germany
PublicationPlace_xml – name: Germany
PublicationTitle European journal of clinical pharmacology
PublicationTitleAlternate Eur J Clin Pharmacol
PublicationYear 1991
References 3890912 - Br J Clin Pharmacol. 1985;19 Suppl 2:77S-83S
6491864 - J Pharmacobiodyn. 1984 Jul;7(7):452-64
41551 - Br J Clin Pharmacol. 1979 Oct;8(4):372-3
3912193 - Eur J Clin Pharmacol. 1985;29(4):495-502
445952 - Clin Pharmacol Ther. 1979 Jun;25(6):870-6
7264924 - J Pharm Sci. 1981 Jul;70(7):768-72
6225863 - J Pharmacobiodyn. 1983 Apr;6(4):246-53
7061182 - Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):73-7
7328489 - J Pharmacobiodyn. 1981 Nov;4(11):879-85
2568445 - J Pharm Pharmacol. 1989 Mar;41(3):179-85
7073267 - Antimicrob Agents Chemother. 1982 Feb;21(2):320-2
References_xml – reference: 6225863 - J Pharmacobiodyn. 1983 Apr;6(4):246-53
– reference: 3890912 - Br J Clin Pharmacol. 1985;19 Suppl 2:77S-83S
– reference: 7061182 - Int J Clin Pharmacol Ther Toxicol. 1982 Feb;20(2):73-7
– reference: 3912193 - Eur J Clin Pharmacol. 1985;29(4):495-502
– reference: 2568445 - J Pharm Pharmacol. 1989 Mar;41(3):179-85
– reference: 6491864 - J Pharmacobiodyn. 1984 Jul;7(7):452-64
– reference: 445952 - Clin Pharmacol Ther. 1979 Jun;25(6):870-6
– reference: 7073267 - Antimicrob Agents Chemother. 1982 Feb;21(2):320-2
– reference: 7264924 - J Pharm Sci. 1981 Jul;70(7):768-72
– reference: 7328489 - J Pharmacobiodyn. 1981 Nov;4(11):879-85
– reference: 41551 - Br J Clin Pharmacol. 1979 Oct;8(4):372-3
SSID ssj0015903
Score 1.494039
Snippet The pharmacokinetic behaviour of cefadroxil was dose-dependent in healthy male volunteers following the oral administration of single doses of 5, 15, and 30...
SourceID pubmed
SourceType Index Database
StartPage 179
SubjectTerms Absorption
Adolescent
Adult
Cefadroxil - pharmacokinetics
Cefadroxil - urine
Cephalexin - pharmacokinetics
Dose-Response Relationship, Drug
Drug Interactions
Humans
Kidney - metabolism
Male
Metabolic Clearance Rate
Reference Values
Title Dose-dependent absorption and elimination of cefadroxil in man
URI https://www.ncbi.nlm.nih.gov/pubmed/1743250
Volume 41
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NaxsxEBVxQsGXkn6YtkmDDiWXWsWrlbzaSyCkKaY0xRQbfDP6BEPrNbYLbX99RivZWid1SHtZFgnE7r7nYWY88wahd9qPbRfKEJrbHmFSGiKZEkQWhuVaaUHroX03X_uDMfs84ZOUyq67S9bqg_7z176S_0EV1gBX3yX7D8huD4UFuAd84QoIw_VRGH-sVpZsxtiu30u1qpbBBPh0uP1eT-zauITaOmmW1a-ZV9nwVat7k_LRQd02TS6SvHWq_ZRLiOt_BiMzSjnVJEswTlYXDAn55ktTQmFu6n7wBSA6lox8iUXGJvbkZY0URDSreUb6ZZgAsjGrLGvQhzZsZBamx9yz3b1NRTqEhbwMraUNEBc_ahR9BEWDVu2Dm3dUtONOC7UgnPDzUX1SJ_7ZxMte1GYOb7GrYhufpo2exDPuBCC1IzI6Rk9jBIEvAx2eoQM7f47OhwGj3108Sh11qy4-x8MGei_QxS5ncOIMBs7gBmdw5XDiDJ7NMXDmJRp_uh5dDUicoUF0nvM1KbzgohWUSyudKbjlomCKSWql0LCkBZcQ8XInvHIcvCgVjvdMKXlpleOOdtDhvJrbVwj34QgB_q02tGDguAudF85k_ZIXipeOvUad8F2miyCUMo0f7M2-jRPUTnQ6RUcOfpf2LTh5a3VWQ3QLiOxRCQ
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dose-dependent+absorption+and+elimination+of+cefadroxil+in+man&rft.jtitle=European+journal+of+clinical+pharmacology&rft.au=Garrigues%2C+T+M&rft.au=Martin%2C+U&rft.au=Peris-Ribera%2C+J+E&rft.au=Prescott%2C+L+F&rft.date=1991-01-01&rft.issn=0031-6970&rft.volume=41&rft.issue=2&rft.spage=179&rft_id=info:doi/10.1007%2FBF00265914&rft_id=info%3Apmid%2F1743250&rft_id=info%3Apmid%2F1743250&rft.externalDocID=1743250
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0031-6970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0031-6970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0031-6970&client=summon